Effect of Mexiletine on Cortical Hyperexcitability in Sporadic Amyotrophic Lateral Sclerosis (SALS)
Phase of Trial: Phase II
Latest Information Update: 28 Feb 2018
At a glance
- Drugs Mexiletine (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- 11 May 2017 Planned End Date changed from 1 Dec 2017 to 1 May 2018.
- 11 May 2017 Planned primary completion date changed from 1 Dec 2017 to 1 May 2018.
- 08 Dec 2016 Status changed from not yet recruiting to recruiting.